UiPath Inc.
PATH
$9.86
$0.0650.66%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| Weiss Ratings | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Good | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.33 | |||
| Price History | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -7.62% | |||
| 30-Day Total Return | -21.81% | |||
| 60-Day Total Return | -23.86% | |||
| 90-Day Total Return | -31.90% | |||
| Year to Date Total Return | -23.63% | |||
| 1-Year Total Return | -54.39% | |||
| 2-Year Total Return | -40.26% | |||
| 3-Year Total Return | -50.48% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -55.30% | |||
| 52-Week Low % Change | 4.37% | |||
| Price | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $21.90 | |||
| 52-Week Low Price | $9.38 | |||
| 52-Week Low Price (Date) | Apr 07, 2025 | |||
| 52-Week High Price (Date) | Apr 09, 2024 | |||
| Valuation | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 5.40B | |||
| Enterprise Value | 3.75B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.13 | |||
| Earnings Per Share Growth | -20.89% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.80 | |||
| Price/Book (Q) | 2.94 | |||
| Enterprise Value/Revenue (TTM) | 2.63 | |||
| Price | $9.88 | |||
| Enterprise Value/EBITDA (TTM) | -30.51 | |||
| Enterprise Value/EBIT | -27.23 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 555.37M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 844 432 0455 | |||
| Address | One Vanderbilt Avenue New York, NY 10017 | |||
| Website | www.uipath.com | |||
| Country | United States | |||
| Year Founded | 2005 | |||
| Profitability | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -9.64% | |||
| Profit Margin | -5.15% | |||
| Management Effectiveness | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -2.96% | |||
| Return on Equity | -- | |||
| Income Statement | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.43B | |||
| Total Revenue (TTM) | 1.43B | |||
| Revenue Per Share | $2.57 | |||
| Gross Profit (TTM) | 1.19B | |||
| EBITDA (TTM) | -123.01M | |||
| EBIT (TTM) | -137.84M | |||
| Net Income (TTM) | -73.69M | |||
| Net Income Avl. to Common (TTM) | -73.69M | |||
| Total Revenue Growth (Q YOY) | 4.54% | |||
| Earnings Growth (Q YOY) | 52.71% | |||
| EPS Diluted (TTM) | -0.13 | |||
| EPS Diluted Growth (Q YOY) | 60.31% | |||
| Balance Sheet | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.63B | |||
| Cash Per Share (Q) | $2.93 | |||
| Total Current Assets (Q) | 2.34B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.85B | |||
| Current Ratio (Q) | 2.927 | |||
| Book Value Per Share (Q) | $3.33 | |||
| Total Assets (Q) | 2.87B | |||
| Total Current Liabilities (Q) | 798.92M | |||
| Total Debt (Q) | 77.82M | |||
| Total Liabilities (Q) | 1.02B | |||
| Total Common Equity (Q) | 1.85B | |||
| Cash Flow | PATH - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -45.50M | |||
| Cash from Financing (TTM) | -450.52M | |||
| Net Change in Cash (TTM) | -182.48M | |||
| Levered Free Cash Flow (TTM) | 465.84M | |||
| Cash from Operations (TTM) | 320.57M | |||
